Almirall

23andMe’s First Drug Candidate Licensed to Spanish Pharma Company
23andMe’s First Drug Candidate Licensed to Spanish Pharma Company
Xtalks
23andMe
diagnostics
Almirall
Flag link:
Almirall strikes option deal to buy Bioniz and dermatology drug BNZ-1
Almirall strikes option deal to buy Bioniz and dermatology drug BNZ-1
Pharmaforum
Almirall
Bioniz
skin cancer
alopecia
BNZ-1
M&A
Flag link:
Prosecutors strike yet another pharma kickbacks settlement, this time with Almirall
Prosecutors strike yet another pharma kickbacks settlement, this time with Almirall
Fierce Pharma
Almirall
kickbacks
Aqua Pharmaceuticals
whistleblower lawsuits
Flag link:
Allergan preludes major selloffs with $650M Almirall dermatology sale
Allergan preludes major selloffs with $650M Almirall dermatology sale
Fierce Pharma
Allergan
dermatology
Almirall
M&A
Flag link:
Why AstraZeneca’s Respiratory Segment Is a Key Growth Platform
Why AstraZeneca’s Respiratory Segment Is a Key Growth Platform
Market Realist
AstraZeneca
Symbicort
Pulmicort
Tudorza
Eklira
Duaklir
Almirall
Flag link:
Valeant Pharmaceuticals Intl Inc (VRX) May Have A Buyer For Derma Assets; Finally Some Good News?
Valeant Pharmaceuticals Intl Inc (VRX) May Have A Buyer For Derma Assets; Finally Some Good News?
Bidness, ETC
Valeant Pharmaceuticals
dermatology
M&A
Almirall
Spain
Flag link:
Teva gets FDA OK to market generic Axert
Teva gets FDA OK to market generic Axert
BioPharma Dive
Teva Pharmaceutical
FDA
generics
Axert
Almirall
migraines
Flag link:
AstraZeneca completes takeover of Almirall respiratory franchise
AstraZeneca completes takeover of Almirall respiratory franchise
Pharmaphorum
AstraZeneca
Almirall
respiratory health
Flag link:
AstraZeneca buys Almirall lung drugs for up to $2.1 billion
AstraZeneca buys Almirall lung drugs for up to $2.1 billion
Yahoo/Reuters
M&A
AstraZeneca
Almirall
respiratory health
Flag link:
Almirall Drops on U.S. Regulator’s Scrutiny of Lung Drug
Almirall Drops on U.S. Regulator’s Scrutiny of Lung Drug
Bloomberg
Almirall
FDA
Forest Labs
COPD
formoterol
aclidinium
Flag link:
This Week in Biotech
This Week in Biotech
Motley Fool
Osiris Therapeutics
Inovio
GSK
Gilead Sciences
Forrest
Almirall
Theravance
MannKind
Flag link:
Forest Labs, Almirall delay NDA filing for Aclidinium/formoterol combination
Forest Labs, Almirall delay NDA filing for Aclidinium/formoterol combination
Yahoo/Fly on the Wall
Forest Labs
Almirall
COPD
aclidinium bromide
formoterol fumarate
Flag link:
Almirall, Forest report positive results in inhaler trial
Almirall, Forest report positive results in inhaler trial
Reuters
Almirall
Forest Labs
COPD
Genuair
Flag link:
European Medicines Agency has recommendations for Novartis, Pfizer, Bristol-Myers Squibb and others
European Medicines Agency has recommendations for Novartis, Pfizer, Bristol-Myers Squibb and others
Pharma Times, UK
Pfizer
Bristol-Myers Squibb
Eliquis
stroke
IBS
Almirall
Novartis
Europe
Flag link:
FDA extends review period for Forest Lab lung drug
FDA extends review period for Forest Lab lung drug
Reuters
COPD
Forest Labs
FDA
Almirall
Flag link:
U.S. panel backs Forest Labs drug for smoker's cough
U.S. panel backs Forest Labs drug for smoker's cough
Reuters
Forest Labs
COPD
Almirall
aclidinium bromide
Flag link:
US FDA staff focus on safety of Forest lung drug
US FDA staff focus on safety of Forest lung drug
Reuters
FDA
Forest Labs
COPD
aclidinium bromide
Almirall
Flag link:
Forest Seeks FDA Nod for COPD Drug
Forest Seeks FDA Nod for COPD Drug
Yahoo/Zacks.com
FDA
Forest Labs
COPD
Almirall
aclidinium bromide
Flag link:
Forest/Almirall's COPD drug filed in USA
Forest/Almirall's COPD drug filed in USA
Pharma Times, UK
Forest Labs
Almirall
COPD
FDA
aclidinium
Flag link:
Forest Labs says lung drug met study goals
Forest Labs says lung drug met study goals
Yahoo/AP
Forest Labs
aclidinium
Almirall
Flag link:

Pages